Skip to content
Screener

PROCEPT BioRobotics Corporation PRCT Current Debt

Current Debt at other companies

TFX
TeleflexTFX
$87.5M-12.5%
Apyx Medical Corporation logo
Apyx Medical CorporationAPYX
$21K+5.0%
InfuSystem Holdings logo
InfuSystem HoldingsINFU
$0—
Novanta logo
NovantaNOVT
$41.5M+698%
ROP
Roper Technologies, Inc.ROP
$718.3M-28.2%
Medtronic logo
MedtronicMDT
$1.79B-37.8%

Other financials

Income statement

See full
Revenue$94.5M+19.3%
Gross profit$62.4M+20.5%
Operating income-$27.4M-23.4%
Net income-$26.9M-37.2%
EPS (diluted)-$0.47-34.3%

Balance sheet

See full
Cash & equivalents$11.4M-96.3%
Total debt$77.5M-2.4%
Total equity$340.1M-11.9%
Total assets$479.4M-6.6%

Cash flow

See full
Operating cash flow-$19.3M-28.0%
CapEx$3.0M+5.4%
Free cash flow-$22.2M-24.4%

Valuation

See full
Market cap$1.15B-25.9%
Enterprise value$1.21B—
P/S3.4×—

Profitability

See full
Gross margin64.2%0.0pp
Operating margin-33.9%+0.5pp
Net margin-32.5%+2.2pp
FCF margin-25.2%-4.6pp

Returns & leverage

See full
Return on equity-30.2%+5.2pp
Debt / equity0.2×0.0×
Current ratio6.5×-2.7×

Where this comes from

Reported directly by PROCEPT BioRobotics Corporation in its filing.

Tagged under the XBRL concept us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths.

The source filing: PROCEPT BioRobotics Corporation’s 10-Q, filed August 5, 2026. Open the filing →

Filed
Aug 5, 2026, 4:14 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001588978-26-000030

FAQ

What is PROCEPT BioRobotics Corporation's current debt?
PROCEPT BioRobotics Corporation (PRCT) reported current debt of $0 in Q2 2026.
What does current debt mean?
The portion of long-term debt maturing within the next 12 months, requiring refinancing or repayment from operating cash flows.

Ask your AI about PROCEPT BioRobotics Corporation's current debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude